Johnson & Johnson
JNJ
ISIN null / Valor 943981
Johnson & Johnson
UMushroom community rating:
About company
Johnson & Johnson is a diversified global healthcare company headquartered in New Brunswick, N.J., that, after spinning off its consumer‑health brands into Kenvue in 2023, is primarily organized around pharmaceuticals (Janssen) and medical devices. Its pharmaceutical business develops and commercializes prescription drugs and biologics across areas such as immunology, oncology, infectious disease and neuroscience, while its medtech operations supply a broad range of hospital and clinic products — including orthopedics, surgery, interventional solutions and vision care — sold through commercial and institutional channels worldwide. The company combines internal R&D with partnerships and acquisitions to advance its pipeline, operates global manufacturing and distribution networks, and is subject to the regulatory, reimbursement and litigation risks typical for large health‑care manufacturers.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
617006 M
Market cap (USD)
10,942,147
Daily traded volume (Shares)
144.88 / 142.96
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Nadja Noth
J Q
Pietro Padovani
EQUITIES OF THE SAME SECTOR
